Testing a natural supplement for childhood obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a supplement made from a natural source (genistein from Sophora japonica) can help children and teens with obesity who are already in a weight management program. It aims to see if the supplement leads to better weight outcomes than the program alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 4 and 17 years old.
- You have obesity, based on your BMI compared to other kids your age and sex.
- You have been in the HEAL weight management program for at least 3 months without losing weight.
- You are not allergic to Sophora japonica (the plant the supplement comes from).
- You do not have type 2 diabetes.
- You are not currently taking certain weight-loss or ADHD medications (like Saxenda, Wegovy, Concerta, or Risperidone).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests a natural supplement (elénzia CONTROL®) to help with weight loss and metabolic health. Researchers want to see if it works for people who have never used GLP-1 medications or who have stopped using them.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.